The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Proteins
The EMBO Journal (2006) 25, 5742–5753, doi:10.1038/sj.emboj.7601450
Published online 30 November 2006
hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37
Xiao-Bo Qiu1, 2, 4, Song-Ying Ouyang1, 4, Chao-Jun Li3, Shiying Miao1, Linfang Wang1 and Alfred L Goldberg2
1 National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University, Beijing, China
2 Department of Cell Biology, Harvard Medical School, Boston, MA, USA
3 Jiangsu Key Laborotory for Molecular & Medical Biotechnology, Nanjing Normal University, Nanjing, China
4 These authors contributed equally to this work

To whom correspondence should be addressed

Xiao-Bo Qiu, National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University, 5 Dongdan Santiao, Beijing, China. Tel.: +86 10 6510 5048; Fax: +86 10 6524 0529; E-mail: xbqiu@yahoo.com
Alfred L Goldberg, Department of Cell Biology, Harvard Medical School, Boston, MA, USA. Tel.: +1 617 432 1855; Fax: +1 617 232 0173; E-mail: Alfred_Goldberg@hms.harvard.edu

Received 5 May 2006; Accepted 24 October 2006; Published online 30 November 2006.
Abstract
The 26S proteasome catalyzes the degradation of most proteins in mammalian cells. To better define its composition and associated regulatory proteins, we developed affinity methods to rapidly purify 26S proteasomes from mammalian cells. By this approach, we discovered a novel 46-kDa (407 residues) subunit of its 19S regulatory complex (previously termed ADRM1 or GP110). As its N-terminal half can be incorporated into the 26S proteasome and is homologous to Rpn13, a 156-residue subunit of the 19S complex in budding yeast, we renamed it human Rpn13 (hRpn13). The C-terminal half of hRpn13 binds directly to the proteasome-associated deubiquitinating enzyme, UCH37, and enhances its isopeptidase activity. Knockdown of hRpn13 in 293T cells increases the cellular levels of ubiquitin conjugates and decreases the degradation of short-lived proteins. Surprisingly, an overproduction of hRpn13 also reduced their degradation. Furthermore, transfection of the C-terminal half of hRpn13 slows proteolysis and induces cell death, probably by acting as a dominant-negative form. Thus in human 26S proteasomes, hRpn13 appears to be important for the binding of UCH37 to the 19S complex and for efficient proteolysis.
Keywords: deubiquitination, hRpn13, proteasome, ubiquitin, UCH37
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

]> Nature Structural & Molecular Biology 13 3 200603 ...

Nature Structural & Molecular Biology News and Views (01 Mar 2006)

Signaling degradation

Nature Structural & Molecular Biology News and Views (01 Sep 2004)

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization